Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 23 December, 2024
Author: Getaka|Social: Getaka Financial Technology X (Earlier Twitter) Profile Getaka Financial Technology LinkedIn Logo

Indraprastha Medical Corporation Ltd: Fundamental Analysis, Share Price Insights & Intrinsic Value (2024)

Share Price and Basic Stock Data

Last Updated: December 21, 2024, 2:23 am

Market Cap 4,495 Cr.
Current Price 490
High / Low 530/154
Stock P/E30.4
Book Value 57.2
Dividend Yield0.92 %
ROCE38.4 %
ROE29.1 %
Face Value 10.0
PEG Ratio1.60

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Indraprastha Medical Corporation Ltd

Competitors of

Stock NameMarket CapCurrent PriceHigh / LowStock P/EBook ValueDividend YieldROCEROEFace Value
NG Industries Ltd 61.0 Cr. 182 230/13610.4 1241.92 %6.50 %5.63 % 10.0
Global Longlife Hospital and Research Ltd 32.0 Cr. 30.5 61.7/27.0 25.90.00 %2.51 %4.72 % 10.0
Gian Lifecare Ltd 19.7 Cr. 19.0 29.0/17.04.83 19.20.00 %29.2 %24.6 % 10.0
Fortis Malar Hospitals Ltd 112 Cr. 59.8 108/44.0 15.971.1 %3.29 %9.12 % 10.0
Family Care Hospitals Ltd 36.6 Cr. 6.78 10.3/6.230.88 2.670.00 %15.4 %24.1 % 10.0
Industry Average25,310.13 Cr771.9753.8689.623.15%12.34%12.42%9.12

All Competitor Stocks of

Quarterly Result

MonthSep 2020Dec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
Sales141180198203233237216263284277274307317
Expenses132154168173208205188226241240241259267
Operating Profit9263030253128374437334750
OPM %7%14%15%15%11%13%13%14%15%13%12%15%16%
Other Income0000012113544
Interest1111111111111
Depreciation8889999101010101010
Profit before tax0172121162220273429274044
Tax %-2%29%28%25%26%28%24%24%26%29%27%24%25%
Net Profit0121515121615202521203033
EPS in Rs0.051.311.651.681.321.741.662.212.742.282.163.333.58

Last Updated: Unknown

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: Unknown

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023TTM
Sales5226076787147557667537888316138881,0991,174
Expenses4555285876306756866787067435727689471,007
Operating Profit67799185807974828741120152168
OPM %13%13%13%12%11%10%10%10%11%7%14%14%14%
Other Income11111-0-1-1-0-0-3916
Interest69108789763343
Depreciation22262828353131303333353940
Profit before tax404554503941344548479117140
Tax %33%37%35%34%37%36%38%36%9%46%26%26%
Net Profit27293532242621284425986104
EPS in Rs2.953.143.873.542.662.862.303.104.760.256.399.4011.35
Dividend Payout %54%51%47%51%68%63%65%52%0%0%39%32%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2012-20132013-20142014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-2023
YoY Net Profit Growth (%)7.41%20.69%-8.57%-25.00%8.33%-19.23%33.33%57.14%-95.45%2850.00%45.76%
Change in YoY Net Profit Growth (%)0.00%13.28%-29.26%-16.43%33.33%-27.56%52.56%23.81%-152.60%2945.45%-2804.24%

Indraprastha Medical Corporation Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2012-2013 to 2022-2023.

Growth

Compounded Sales Growth
10 Years:6%
5 Years:10%
3 Years:27%
TTM:12%
Compounded Profit Growth
10 Years:13%
5 Years:34%
3 Years:258%
TTM:42%
Stock Price CAGR
10 Years:24%
5 Years:65%
3 Years:88%
1 Year:173%
Return on Equity
10 Years:17%
5 Years:20%
3 Years:25%
Last Year:29%

Last Updated: Unknown

Balance Sheet

Last Updated: November 14, 2024, 11:30 pm

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Sep 2024
Equity Capital92929292929292929292929292
Reserves7995103132139141152176181234288386433
Borrowings7363505267662143523433
Other Liabilities194199196185160134157177157131173212249
Total Liabilities438449442460458432422449432462555723806
Fixed Assets300293286301296294280303283277275347341
CWIP0233001030300
Investments0000000000000
Other Assets138154153157163138141146145185278376465
Total Assets438449442460458432422449432462555723806

Reserves and Borrowings Chart

Cash Flow

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Cash from Operating Activity +67586462284875862794144200
Cash from Investing Activity +-54-22-29-33-22-30-17-40-19-74-108-158
Cash from Financing Activity +-13-36-35-30-5-17-44-43-3-3-26-32
Net Cash Flow00-0-0-01144517119

Free Cash Flow

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Free Cash Flow67.006.0028.0035.0028.0012.008.0061.0083.0038.00115.00150.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Debtor Days323540414741353540182317
Inventory Days
Days Payable
Cash Conversion Cycle323540414741353540182317
Working Capital Days-28-19-2301412-5-80-1-11-24
ROCE %23%26%23%18%17%15%19%21%3%29%34%38%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthSep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
Promoters51.00%51.00%51.00%51.00%51.00%51.00%51.00%51.00%51.00%51.00%51.00%51.00%
FIIs0.03%0.18%0.14%0.09%0.15%0.77%0.27%0.37%0.81%0.95%1.08%1.70%
DIIs0.02%0.02%0.02%0.02%0.02%0.00%0.00%0.00%6.71%6.36%4.91%3.14%
Public48.96%48.80%48.84%48.89%48.83%48.22%48.72%48.62%41.49%41.69%43.01%44.14%
No. of Shareholders58,00157,25456,54055,29055,28752,76049,83348,63047,86551,44854,15855,103

Shareholding Pattern Chart

No. of Shareholders

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
Motilal Oswal S&P BSE Healthcare ETF3840.080.013842024-12-170%

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 24Mar 23Mar 22Mar 21Mar 20
FaceValue10.0010.0010.0010.0010.00
Basic EPS (Rs.)13.529.406.390.254.76
Diluted EPS (Rs.)13.529.406.390.254.76
Cash EPS (Rs.)17.8913.6810.213.898.36
Book Value[Excl.RevalReserv]/Share (Rs.)52.1241.3935.5029.7529.21
Book Value[Incl.RevalReserv]/Share (Rs.)52.1241.3935.5029.7529.21
Dividend / Share (Rs.)4.503.002.500.000.00
Revenue From Operations / Share (Rs.)135.78119.8596.8966.9190.62
PBDIT / Share (Rs.)22.9317.5312.814.479.50
PBIT / Share (Rs.)18.5613.259.000.835.90
PBT / Share (Rs.)18.1212.788.630.465.26
Net Profit / Share (Rs.)13.529.406.390.254.76
PBDIT Margin (%)16.8914.6213.226.6710.48
PBIT Margin (%)13.6711.059.281.246.51
PBT Margin (%)13.3410.668.900.695.80
Net Profit Margin (%)9.957.846.600.375.25
Return on Networth / Equity (%)25.9422.7018.010.8516.28
Return on Capital Employeed (%)30.5028.5422.402.4117.48
Return On Assets (%)17.1315.5112.690.539.71
Total Debt / Equity (X)0.000.000.000.000.01
Asset Turnover Ratio (%)1.952.161.991.391.91
Current Ratio (X)1.861.721.681.221.01
Quick Ratio (X)1.821.661.581.140.92
Inventory Turnover Ratio (X)0.0021.0018.5510.9514.88
Dividend Payout Ratio (NP) (%)22.1826.600.000.000.00
Dividend Payout Ratio (CP) (%)16.7618.270.000.000.00
Earning Retention Ratio (%)77.8273.400.000.000.00
Cash Earning Retention Ratio (%)83.2481.730.000.000.00
Interest Coverage Ratio (X)51.7937.5534.4312.2714.72
Interest Coverage Ratio (Post Tax) (X)31.5321.1318.191.708.37
Enterprise Value (Cr.)1350.00583.80467.36465.22291.19
EV / Net Operating Revenue (X)1.080.530.520.750.35
EV / EBITDA (X)6.423.633.9811.363.34
MarketCap / Net Operating Revenue (X)1.260.640.600.800.37
Retention Ratios (%)77.8173.390.000.000.00
Price / BV (X)3.301.881.651.811.16
Price / Net Operating Revenue (X)1.260.640.600.800.37
EarningsYield0.070.120.100.000.14

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Indraprastha Medical Corporation Ltd as of December 23, 2024 is: 510.67

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of December 23, 2024, Indraprastha Medical Corporation Ltd is Undervalued by 4.22% compared to the current share price 490.00

Intrinsic Value of Indraprastha Medical Corporation Ltd as of December 23, 2024 is: 607.60

Calculation basis:

  • Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of December 23, 2024, Indraprastha Medical Corporation Ltd is Undervalued by 24.00% compared to the current share price 490.00

Last 5 Year EPS CAGR: 18.98%

*Investments are subject to market risks

Strength and Weakness

StrengthWeakness
  1. The stock has a high average ROCE of 22.17%, which is a positive sign.
  2. The stock has a low average Working Capital Days of -7.75, which is a positive sign.
  3. The company has higher reserves (195.31 cr) compared to borrowings (36.38 cr), indicating strong financial stability.
  4. The company has shown consistent growth in sales (609.00 cr) and profit (56.62 cr) over the years.
  1. The stock has a high average Cash Conversion Cycle of 33.67, which may not be favorable.

Stock Analysis

  • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Indraprastha Medical Corporation Ltd:
    1. Net Profit Margin: 9.95%
      • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
    2. ROCE: 30.5% (Industry Average ROCE: 12.34%)
      • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
    3. ROE%: 25.94% (Industry Average ROE: 12.42%)
      • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
    4. Interest Coverage Ratio (Post Tax): 31.53
      • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
    5. Quick Ratio: 1.82
      • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
    6. Stock P/E: 30.4 (Industry average Stock P/E: 53.86)
      • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
    7. Total Debt / Equity: 0
      • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
    The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
    Stock Rating:

About the Company - Qualitative Analysis

Indraprastha Medical Corporation Ltd. is a Public Limited Listed company incorporated on 16/03/1988 and has its registered office in the State of Delhi, India. Company’s Corporate Identification Number(CIN) is L24232DL1988PLC030958 and registration number is 030958. Currently company belongs to the Industry of Hospitals & Medical Services. Company’s Total Operating Revenue is Rs. 888.16 Cr. and Equity Capital is Rs. 91.67 Cr. for the Year ended 31/03/2022.
INDUSTRYADDRESSCONTACT
Hospitals & Medical ServicesSarita Vihar, Delhi-Mathura Road, New Delhi Delhi 110076imclshares@apollohospitals.com
delhi.apollohospitals.com
Management
NamePosition Held
Dr. Prathap C ReddyVice Chairman
Mr. Pattabhiraman ShivakumarManaging Director
Dr.(Ms.) Suneeta ReddyDirector
Mr. Vinayak ChatterjeeDirector
Ms. Vineeta RaiDirector
Ms. Madhumita GanguliDirector
Dr. Menaka GuruswamiDirector
Dr.(Ms.) Sangita ReddyDirector
Dr. Arun RaiDirector
Prof. (Dr) Mahesh VermaDirector
Mr. Salil SinghalDirector
Mr. Sandip SomanyDirector
Mr. Tejpreet Singh ChopraDirector

FAQ

What is the latest intrinsic value of ?

The latest intrinsic value of as on 22 December 2024 is ₹510.67, which is 4.22% higher than the current market price of ₹490.00. The stock has a market capitalization of 4,495 Cr. and recorded a high/low of 530/154 during the current fiscal year 2024-2025. As of Sep 2024, the company has reserves of ₹433 Cr and total liabilities of ₹806 Cr.

What is the Market Cap of ?

The Market Cap of is 4,495 Cr..

What is the current Stock Price of as on 22 December 2024?

The current stock price of as on 22 December 2024 is 490.

What is the High / Low of stocks in FY 2024-2025?

In FY 2024-2025, the High / Low of stocks is 530/154.

What is the Stock P/E of ?

The Stock P/E of is 30.4.

What is the Book Value of ?

The Book Value of is 57.2.

What is the Dividend Yield of ?

The Dividend Yield of is 0.92 %.

What is the ROCE of ?

The ROCE of is 38.4 %.

What is the ROE of ?

The ROE of is 29.1 %.

What is the Face Value of ?

The Face Value of is 10.0.

About the Author

Author Avatar
Getaka

Getaka, CFA, a financial analyst with 15 years of experience in the industry. Getaka holds an MBA degree and the Chartered Financial Analyst designation, demonstrating his profound understanding of financial analysis and investment management. Throughout his career, he has conducted numerous financial analyses and due diligence processes for companies in the industry, and has a strong track record of identifying key trends and opportunities. He leverages his expertise to deliver a thorough financial analysis of a company, encompassing its financial performance, key ratios, future prospects, and risks. Getaka is committed to providing accurate, reliable, and trustworthy information to help readers make informed decisions about their finances and investments.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Indraprastha Medical Corporation Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE